Tempest Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2013 | — | $41.7M | $18.1M |
| FY2014 | — | $55.3M | $6.4M |
| FY2015 | — | $126.9M | $43.2M |
| FY2016 | — | $108.2M | $43.9M |
| FY2017 | $599.0K | $-130.7M | $17.6M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2013 | — | $41.7M | $18.1M |
| FY2014 | — | $55.3M | $6.4M |
| FY2015 | — | $126.9M | $43.2M |
| FY2016 | — | $108.2M | $43.9M |
| FY2017 | $599.0K | $-130.7M | $17.6M |